Protagenic Therapeutics, Inc.
PTIX
$0.49
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | 2.21M | -869.50K | -5.06M | -850.30K | |
| Total Depreciation and Amortization | 12.60K | 12.60K | 12.60K | -- | |
| Total Amortization of Deferred Charges | 0.00 | 0.00 | 243.40K | 180.00K | |
| Total Other Non-Cash Items | -3.02M | -97.50K | 3.19M | -- | |
| Change in Net Operating Assets | 283.10K | -441.00K | 448.30K | 316.60K | |
| Cash from Operations | -509.70K | -1.40M | -1.17M | -353.60K | |
| Capital Expenditure | -- | -- | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | 0.00 | 0.00 | 943.20K | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -- | -1.22M | |
| Cash from Investing | 0.00 | 0.00 | 943.20K | -1.22M | |
| Total Debt Issued | 0.00 | -15.40K | 77.80K | 150.20K | |
| Total Debt Repaid | -- | -- | -- | 1.06M | |
| Issuance of Common Stock | -- | 0.00 | 4.35M | 0.00 | |
| Repurchase of Common Stock | 0.00 | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | 157.00K | |
| Cash from Financing | 0.00 | -15.40K | 4.42M | 1.37M | |
| Foreign Exchange rate Adjustments | -100.00 | 37.10K | -117.20K | 211.60K | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -509.80K | -1.37M | 4.08M | 8.20K | |